The authors of this paper assert that an updated treatment model is needed globally for people with hemophilia, one that ulitmately strives for health equity for all.
BioMarin is working with health authorities and governmental regulatory agencies globally, to ensure the safety of all those involved in their clinical trial program, including enrolled participants, investigators, and staff.
Information and techniques you and your family can use to stay healthy during the COVID-19 pandemic.
The National Hemophilia Foundation will be holding our quarterly Board of Directors meeting on Thursday, May 28th at 7:00 PM EDT.
Researchers for this observational study focused on macroscopic hematuria, hemophilia, and potential links to family history of hypertension.
Many questions and concerns exist in our community and NHF is here to help you navigate the complexities of the pandemic.
Important updates regarding NHF's 72nd Bleeding Disorders Conference.
The executive summary of the NHF/HFA Safety Summit is available for public commentary.
Many of us are looking for new ways to stay active during the COVID-19 pandemic, but it’s important to find an activity that works for you and your bleeding disorder.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car